Satellos Bioscience Announces Closing of Previously Announced Non-Brokered Offering of $2.385 Million of Unsecured Non-Convertible ...
Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - Satellos Bioscience Inc. MSCL MSCLF ("Satellos" or the "Company"), a drug discovery company developing small molecule therapeutics to regenerate muscle as a new approach to treating …